NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

TXG

10x Genomics Inc

Jun 30 • 04:00PM ET

11.58

Dollar change -0.15
Percentage change -1.28	%

Healthcare • Health Information Services • USA • NASD

Peers: ILMN NTRA PACB FLGT CDNA MYGN GH EXAS QDEL TWST

| Held by: ARKK ARKG VTI IWM VB VXF VBK IWN IBB SCHA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.30	Insider Own	15.39%	Shs Outstand	109.08M	Perf Week	7.32%
Market Cap	1.45B	Forward P/E	-	EPS next Y	-0.95	Insider Trans	0.01%	Shs Float	105.63M	Perf Month	24.05%
Enterprise Value	1.10B	PEG	-	EPS next Q	-0.37	Inst Own	90.00%	Short Float	12.72%	Perf Quarter	26.42%
Income	-157.04M	P/S	2.31	EPS this Y	19.15%	Inst Trans	4.68%	Short Ratio	3.29	Perf Half Y	-21.06%
Sales	624.66M	P/B	2.02	EPS next Y	22.40%	ROA	-17.20%	Short Interest	13.43M	Perf YTD	-19.36%
Book/sh	5.74	P/C	3.39	EPS next 5Y	24.74%	ROE	-22.03%	52W High	24.76 -53.23%	Perf Year	-40.62%
Cash/sh	3.42	P/FCF	31.87	EPS past 3/5Y	-42.17% -36.10%	ROIC	-20.20%	52W Low	6.78 70.80%	Perf 3Y	-75.08%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.59% 19.96%	Gross Margin	70.75%	Volatility	6.33% 5.93%	Perf 5Y	-87.01%
Dividend TTM	-	EV/Sales	1.76	EPS Y/Y TTM	42.17%	Oper. Margin	-29.01%	ATR (14)	0.62	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.68	Sales Y/Y TTM	-0.13%	Profit Margin	-25.14%	RSI (14)	67.16	Recom	2.32
Dividend Gr. 3/5Y	- -	Current Ratio	5.37	EPS Q/Q	44.19%	SMA20	10.00%	Beta	2.03	Target Price	13.00
Payout	-	Debt/Eq	0.11	Sales Q/Q	9.84%	SMA50	23.56%	Rel Volume	0.76	Prev Close	11.73
Employees	1306	LT Debt/Eq	0.10	Earnings	May 08 AMC	SMA200	-12.39%	Avg Volume	4.09M	Price	11.58
IPO	Sep 12, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.09% 16.34%	Trades		Volume	3,126,583	Change	-1.28%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$25 → $12
Sep-03-24	Initiated	Leerink Partners	Outperform	$35
Jul-22-24	Upgrade	Jefferies	Hold → Buy	$24
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral	$40 → $20
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold	$55 → $25
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold	$24
May-01-24	Downgrade	TD Cowen	Buy → Hold	$57 → $32
Dec-14-23	Initiated	Guggenheim	Buy	$60
Dec-13-23	Initiated	Wolfe Research	Outperform	$55
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral	$36 → $54
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-10-23	Initiated	Barclays	Overweight	$65
Mar-31-23	Initiated	Stephens	Overweight	$65
Feb-02-23	Initiated	UBS	Neutral	$50
Dec-14-22	Initiated	Deutsche Bank	Buy	$50
Aug-18-22	Downgrade	Goldman	Neutral → Sell	$55 → $35
Jul-25-22	Initiated	Canaccord Genuity	Buy	$55
Jul-15-22	Downgrade	William Blair	Outperform → Mkt Perform

Show Previous Ratings

Jun-23-25 11:34PM	Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) (StockStory)
01:39AM	10x Genomics Settles Patent Dispute With Bruker (Insider Monkey)
Jun-10-25 06:23AM	TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions (StockStory) +5.55%
May-29-25 09:55AM	Wall Street Analysts Think 10x Genomics (TXG) Could Surge 43.12%: Read This Before Placing a Bet (Zacks) +5.36%
May-23-25 07:41AM	Why 10x Genomics Stock Was Sliding This Week (Motley Fool)
02:00AM	Loading…
May-22-25 02:00AM	Trump Funding Cuts Are Roiling Science. These Stocks May Be Hardest Hit. (Barrons.com)
May-21-25 12:00PM	10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know (Zacks) -8.37%
May-14-25 04:05PM	10x Genomics Announces Patent Litigation Settlement Agreement with Bruker (PR Newswire) -5.49%
01:32PM	Bruker and 10x Genomics settle patent dispute (Medical Device Network)
May-13-25 09:55AM	Wall Street Analysts Believe 10x Genomics (TXG) Could Rally 55.85%: Here's is How to Trade (Zacks)
May-09-25 03:42AM	10x Genomics Inc (TXG) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
May-08-25 07:00PM	Compared to Estimates, 10x Genomics (TXG) Q1 Earnings: A Look at Key Metrics (Zacks)
05:50PM	10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:53PM	10x Genomics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports First Quarter 2025 Financial Results (PR Newswire)
05:20PM	Loading…
May-07-25 05:20PM	10x Genomics Q1 2025 Earnings Preview (Seeking Alpha)
May-01-25 10:01AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-25 04:05PM	10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference (PR Newswire)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)
09:09AM	3 Cash-Heavy Stocks in the Doghouse (StockStory)
Apr-14-25 04:05PM	10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025 (PR Newswire)
Apr-09-25 05:04AM	Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks (StockStory) +21.43%
Mar-20-25 03:12AM	10x Genomics: Lower Cost Innovation May Drive A Rebound (SeekingAlpha)
Mar-18-25 07:00AM	These 10 biotech companies are changing how we discover new drugs and treat complex diseases (FastCompany)
Mar-11-25 05:03AM	2 Reasons to Sell TXG and 1 Stock to Buy Instead (StockStory)
Mar-03-25 04:05PM	10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products (PR Newswire) -7.86% +6.80%
08:03AM	1 Stock Under $50 on Our Watchlist and 2 to Ignore (StockStory)
Feb-23-25 11:30AM	10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis (PR Newswire)
Feb-18-25 04:05PM	10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference (PR Newswire)
Feb-13-25 03:10PM	Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties (Benzinga)
01:57PM	Loading…
01:57PM	Trumps Cuts to Medical Research Are Hurting These Stocks (Barrons.com)
01:53PM	Why 10x Genomics (TXG) Shares Are Falling Today (StockStory)
09:42AM	10x Genomics Shares Tumble on Fear Over Cuts to NIH (Barrons.com)
07:36AM	Q4 2024 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
02:16AM	10x Genomics Inc (TXG) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Feb-12-25 06:30PM	Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings (Zacks)
05:45PM	10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:41PM	10x Genomics: Q4 Earnings Snapshot (Associated Press Finance)
04:39PM	10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations (StockStory)
04:05PM	10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025 (PR Newswire)
Feb-11-25 09:15AM	Seeking Clues to 10x Genomics (TXG) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:06AM	10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-06-25 08:08PM	10x Genomics, Inc. (TXG): Among Cathie Woods Top Stock Picks for 2025 (Insider Monkey)
08:30AM	Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology (PR Newswire)
Feb-05-25 10:00AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jan-28-25 04:05PM	10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025 (PR Newswire)
Jan-12-25 12:00PM	10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results (PR Newswire)
Jan-08-25 07:30PM	Colorados Most Expensive Home for Sale Is Listing for $78 Million (The Wall Street Journal)
Jan-02-25 04:05PM	10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire) +9.94%
Dec-30-24 09:28AM	Bruker seeks to pause injunction of GeoMx in the US after court ruling (Medical Device Network)
Dec-24-24 07:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Dec-23-24 04:05PM	U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products (PR Newswire)
Nov-20-24 03:29PM	If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer (Barrons.com)
Nov-19-24 07:11PM	10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
Nov-07-24 04:05PM	10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference (PR Newswire)
Oct-31-24 08:00AM	TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative (PR Newswire)
Oct-30-24 07:36AM	Q3 2024 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
03:14AM	10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Oct-29-24 07:00PM	10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:20PM	10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:15PM	10x Genomics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Third Quarter 2024 Financial Results (PR Newswire)
Oct-23-24 12:00PM	10x Genomics (TXG) Upgraded to Strong Buy: Here's Why (Zacks)
Oct-22-24 10:01AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-15-24 04:05PM	10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches (PR Newswire)
Oct-10-24 04:14PM	These Stocks Moved the Most Today: Tesla, Super Micro, AMD, and More (Barrons.com) -24.70%
01:26PM	These Stocks Are Moving the Most Today: Tesla, Delta, Super Micro, First Solar, AMD, 10x Genomics, PayPal, and More (Barrons.com)
07:36AM	Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead (Benzinga)
Oct-09-24 05:57PM	10x Genomics Inc (TXG) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst Macroeconomic ... (GuruFocus.com)
04:05PM	10x Genomics Announces Preliminary Select Third Quarter 2024 Results (PR Newswire)
Oct-04-24 05:05PM	Vanguard Group's Strategic Acquisition in 10x Genomics Inc (GuruFocus.com)
Oct-01-24 04:05PM	10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting (PR Newswire) -5.62% -5.54%
Sep-10-24 09:00AM	Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer (PR Newswire)
Sep-03-24 04:05PM	10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research (PR Newswire)
Aug-22-24 04:05PM	10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) +5.57%
Aug-12-24 03:01PM	Catherine Wood's Strategic Acquisition in 10x Genomics Inc. (GuruFocus.com)
Aug-08-24 06:00PM	10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +7.83%
05:45PM	10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:45PM	10x Genomics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Announces Senior Leadership Changes (PR Newswire)
04:04PM	10x Genomics Reports Second Quarter 2024 Financial Results (PR Newswire)
Aug-07-24 09:15AM	Unlocking Q2 Potential of 10x Genomics (TXG): Exploring Wall Street Estimates for Key Metrics (Zacks)
Aug-05-24 04:00PM	10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases (PR Newswire)
Aug-01-24 10:01AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-21-24 11:49PM	10x Genomics, Inc. (TXG): Hedge Funds Think This Stock Will Skyrocket (Insider Monkey)
Jul-17-24 09:55AM	Does 10x Genomics (TXG) Have the Potential to Rally 85.65% as Wall Street Analysts Expect? (Zacks)
Jul-12-24 09:15AM	10x Genomics (TXG) Surges 8.2%: Is This an Indication of Further Gains? (Zacks)
08:00AM	10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 (PR Newswire)
Jul-10-24 02:10PM	Illumina Deal Sends 10x Genomics Stock Tumbling (Barrons.com) -13.92%
Jun-27-24 09:00AM	New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies (PR Newswire)
Jun-25-24 08:14AM	Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead? (Insider Monkey)
Jun-20-24 09:00AM	10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel (PR Newswire)
Jun-07-24 01:01PM	Baillie Gifford Reduces Stake in 10x Genomics Inc. (GuruFocus.com)
May-29-24 04:05PM	10x Genomics Launches 5,000-Plex Gene Panel for Xenium (PR Newswire)
May-10-24 07:01AM	Shhh! 3 Secret Nanotech Stocks Flying Below Wall Street's Radar (InvestorPlace)
May-07-24 02:45PM	Bruker's NanoString Secures Patent Case Win in Germany (MT Newswires)
May-06-24 01:04PM	Cathie Wood's Latest Buys: 3 Stocks the ARK Invest CEO Can't Get Enough Of (InvestorPlace)
09:08AM	International Markets and 10x Genomics (TXG): A Deep Dive for Investors (Zacks)
May-02-24 04:05PM	10x Genomics to Present at the BofA Securities 2024 Healthcare Conference (PR Newswire)
06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace)

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saxonov Serge	Chief Executive Officer	May 22 '25	Sale	8.30	9,343	77,540	1,083,625	May 27 05:08 PM
Hindson Benjamin J.	See Remarks	May 22 '25	Sale	8.30	7,485	62,120	448,374	May 27 05:07 PM
Taich Adam	Chief Financial Officer	May 22 '25	Sale	8.30	4,044	33,562	331,588	May 27 05:06 PM
Hindson Benjamin J.	Officer	May 22 '25	Proposed Sale	9.08	7,392	67,119		May 22 04:44 PM
Taich Adam	Officer	May 22 '25	Proposed Sale	9.08	3,994	36,266		May 22 04:36 PM
Saxonov Serge	Officer	May 22 '25	Proposed Sale	9.08	9,227	83,781		May 22 04:24 PM
Saxonov Serge	Chief Executive Officer	Mar 04 '25	Option Exercise	1.20	50,000	60,000	921,540	Mar 04 06:50 PM
Saxonov Serge	Chief Executive Officer	Feb 28 '25	Sale	10.63	7,942	84,393	871,540	Mar 04 06:50 PM
Serge Saxonov	Director, CEO	Feb 28 '25	Proposed Sale	10.57	7,942	83,947		Feb 28 05:03 PM
Hindson Benjamin J.	See Remarks	Feb 24 '25	Sale	11.07	4,573	50,603	335,324	Feb 26 05:43 PM
Saxonov Serge	Chief Executive Officer	Feb 24 '25	Sale	11.07	5,092	56,346	879,482	Feb 26 05:42 PM
MATEO ALAN	Director	Feb 21 '25	Buy	11.14	40,000	445,572	61,691	Feb 25 05:22 PM
Saxonov Serge	Officer	Feb 24 '25	Proposed Sale	11.56	5,104	59,002		Feb 24 08:01 PM
Hindson Benjamin J.	Officer	Feb 24 '25	Proposed Sale	11.56	4,563	52,748		Feb 24 07:35 PM
Saxonov Serge	Chief Executive Officer	Dec 23 '24	Option Exercise	1.20	12,000	14,400	884,574	Dec 23 08:29 PM
Saxonov Serge	Chief Executive Officer	Nov 22 '24	Sale	13.69	6,693	91,612	872,574	Nov 25 04:53 PM
Hindson Benjamin J.	See Remarks	Nov 22 '24	Sale	13.69	5,807	79,485	339,897	Nov 25 04:52 PM
Hindson Benjamin J.	Officer	Nov 22 '24	Proposed Sale	13.32	5,734	76,377		Nov 22 04:56 PM
Saxonov Serge	Officer	Nov 22 '24	Proposed Sale	13.32	6,608	88,019		Nov 22 04:38 PM
Saxonov Serge	Chief Executive Officer	Aug 22 '24	Sale	22.53	6,749	152,053	882,467	Aug 26 05:05 PM
Hindson Benjamin J.	See Remarks	Aug 22 '24	Sale	22.53	4,351	98,027	345,704	Aug 26 05:04 PM
McAnear Justin J.	Former Chief Financial Officer	Aug 22 '24	Sale	22.53	2,961	66,710	143,242	Aug 26 05:03 PM
Saxonov Serge	Officer	Aug 22 '24	Proposed Sale	23.01	6,749	155,294		Aug 22 08:45 PM
McAnear Justin J.	Officer	Aug 22 '24	Proposed Sale	23.01	2,961	68,133		Aug 22 08:42 PM
Hindson Benjamin J.	Officer	Aug 22 '24	Proposed Sale	23.01	4,351	100,117		Aug 22 08:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TXG

10x Genomics Inc

Upgrade your FINVIZ experience